Mustang Bio Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights Aug 14, 2017
Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights Aug 11, 2017
Fortress Biotech Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights Aug 09, 2017
Fortress Biotech Announces Filing of Provisional Patent Application for Caelum Biosciences’ CAEL-101 Jul 17, 2017
Fortress Biotech Announces Appointment of Lucy Lu, MD, as President and Chief Executive Officer of Subsidiary Avenue Therapeutics Jul 03, 2017
Fortress Biotech Announces that its Subsidiary, Mustang Bio, Enters into License Agreements with City of Hope for Novel CAR T Immunotherapies Jun 05, 2017
